Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Carnival Corp (CCL) Price & Performance

Adaptive Biotechnologies CorpTrade
Carnival CorpTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Carnival Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Carnival Corp trades at $27.96 (market cap $37.98B). The key difference: Carnival Corp is far larger — about 9.4× Adaptive Biotechnologies Corp's market cap, and Carnival Corp pays a 1.62% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTCCL
Market Cap
$4.04B$37.98B
Sector
HealthConsumer Cyclical
52-Week High
$25.45$33.99
52-Week Low
$12.30$23.89
Enterprise Value
$4.10B$61.91B
Dividend Yield
1.62%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Carnival Corp

Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.

Read more on CCL